RxSight, Inc. Announces Preliminary Second Quarter Financial Results and Product Pipeline Updates Following Strategic Collaboration Agreement
In Aliso Viejo, California, on July 6, 2026, RxSight, Inc. (NASDAQ: RXST) revealed key financial data for the second quarter of 2026 and advancements in its standalone product roadmap. This follows a recent partnership with Alcon to work on light-adjustable Presbyopia-Correcting Intraocular Lenses. The collaboration aims to bolster development and commercialization efforts, enhancing RxSight's position in the market. This move signifies an important step for both companies in the ophthalmic sector.